THESEUS PHARMACEUTICALS INC (THRX) Stock Balance Sheet
NASDAQ:THRX - Nasdaq - US88369M1018 - Common Stock - Currency: USD
| MRQ (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 46.90M | 94.60M | 244.70M | 8.50M | 1.30M | |||
| Marketable Securities | 158.20M | 103.40M | N/A | N/A | N/A | |||
| Other Current Assets | 4.50M | 4.10M | 3.30M | 100.00K | 100.00K | |||
| Total Current Assets | 209.60M | 202.10M | 248.00M | 8.60M | 1.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 4.30M | 4.80M | 0.00 | 0.00 | 0.00 | |||
| Investments And Advances | 20.30M | 13.80M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 400.00K | 1.80M | 2.90M | 0.00 | 0.00 | |||
| Total Non-Current Assets | 25.00M | 20.30M | 2.90M | 0.00 | 0.00 | |||
| TOTAL ASSETS | 234.60M | 222.40M | 250.90M | 8.60M | 1.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 5.30M | 5.80M | 2.10M | 500.00K | 300.00K | |||
| Accounts Payable | 1.30M | 5.00M | 1.00M | 1.10M | 300.00K | |||
| Other Current Liabilities | 300.00K | 300.00K | 600.00K | 0.00 | N/A | |||
| Total Current Liabilities | 7.00M | 11.10M | 3.70M | 1.60M | 600.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 3.10M | 3.70M | 800.00K | 0.00 | 3.40M | |||
| Total Non-Current Liabilities | 3.10M | 3.70M | 800.00K | 0.00 | 3.40M | |||
| TOTAL LIABILITIES | 10.10M | 14.80M | 4.50M | 1.60M | 4.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -155.10M | -112.20M | -61.60M | -34.30M | -10.20M | |||
| Additional Paid In Capital | 379.90M | 320.20M | 308.00M | 0.00 | 800.00K | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 41.30M | 6.90M | |||
| Other Shareholders' Equity | -300.00K | -400.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 43.60M | 38.70M | 38.70M | 37.50M | 37.50M | |||
| Tangible Book Value per Share | 5.15 | 5.36 | 6.37 | -0.91 | -0.25 | |||
| Total Shareholders' Equity | 224.50M | 207.60M | 246.40M | 7.00M | -2.60M | |||
| TOTAL LIABILITIES AND EQUITY | 234.60M | 222.40M | 250.90M | 8.60M | 1.40M | |||
| Statistics | ||||||||
| Current Ratio | 29.94 | 18.21 | 67.03 | 5.38 | 2.33 | |||
| Return On Assets (ROA) | -24.13% | -22.76% | -10.88% | -139.53% | -512.86% | |||
| Return On Equity (ROE) | -25.22% | -24.38% | -11.08% | -171.43% | N/A | |||
All data in USD , ROIC based on taxRate of 0.21